Copyright © 2021. Inderes Oyj. All rights reserved.

CellaVision

Analyst

Latest insider trading

Net impact profile

Third party research
22.10.
2021

Redeyes's first comments on the Q3 report earlier this morning.

Third party research
20.7.
2021

Redeye views the Q2 from Cellavision this morning as very much in line with our expectations and continued solid recovery story.

Third party research
28.4.
2021

Redeye’s first comments on CellaVision’s report for Q1’21. The report showed stronger sales than we expected at SEK 134m vs. our SEK 123m, a flat development compared to last year.

CellaVision